Pyrazine derivatives and their use in the treatment of neurological disorders

Details for Australian Patent Application No. 2010338365 (hide)

Owner Novartis AG

Inventors Tintelnot-Blomley, Marina; Veenstra, Siem Jacob

Agent Davies Collison Cave

Pub. Number AU-A-2010338365

PCT Pub. Number WO2011/080176

Priority 61/291,724 31.12.09 US

Filing date 22 December 2010

Wipo publication date 7 July 2011

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/497 (2006.01)

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/080176 Priority application(s): WO2011/080176

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010338367-An oven door with a plastic door column and a method for assembling said plastic door column

2010338355-Interrogation of wavelength-specfic devices